Stockreport

CymaBay Therapeutics stock down 43% after NASH trial data disappoint investors [MarketWatch]

CymaBay Therapeutics Inc.  (CBAY) 
Last cymabay therapeutics inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cymabay.com
PDF CymaBay Therapeutics stock down 43% after NASH trial data disappoint investors Shares of CymaBay Therapeutics Inc. CBAY, -54.01% plummeted 43% in premarket trade Tues [Read more]